News - Valeant Pharmaceuticals, Neurological


Popular Filters

ISTA Pharma rejects Valeant’s advances; Alexza could be for sale


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) has entered into another…

AdasuveAlexza PharmaceuticalISTA PharmaceuticalMergers & AcquisitionsNeurologicalOphthalmicsPharmaceuticalValeant Pharmaceuticals

BioDelivery pain drug Onsolis to launch in Canada via Meda Valeant


US specialty drug firm BioDelivery Sciences International (Nasdaq: BDSI) says that its pain drug Onsolis…

BioDelivery SciencesMarkets & MarketingMedaMeda ValeantNeurologicalNorth AmericaOnsolisPharmaceuticalValeant Pharmaceuticals

Valeant back on takeover path, now eyeing Sweden’s Meda: Canada OKs Sublinox


Unconfirmed press reports indicate that Canada’s Valeant Pharmaceutical International (NYSE: VRX)…

Markets & MarketingMedaNeurologicalNorth AmericaPharmaceuticalRegulationSublinoxValeant Pharmaceuticals

Back to top